DOCSLIB.ORG

Cyclin D1 Downregulation Contributes to Anticancer Effect of Isorhapontigenin on Human Bladder Cancer Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cyclin D1 Downregulation Contributes to Anticancer Effect of Isorhapontigenin on Human Bladder Cancer Cells Published OnlineFirst May 30, 2013; DOI: 10.1158/1535-7163.MCT-12-0922 Molecular Cancer Cancer Therapeutics Insights Therapeutics Cyclin D1 Downregulation Contributes to Anticancer Effect of Isorhapontigenin on Human Bladder Cancer Cells Yong Fang1,3, Zipeng Cao3, Qi Hou2, Chen Ma2, Chunsuo Yao2, Jingxia Li3, Xue-Ru Wu4, and Chuanshu Huang3 Abstract Isorhapontigenin (ISO) is a new derivative of stilbene compound that was isolated from the Chinese herb Gnetum Cleistostachyum and has been used for treatment of bladder cancers for centuries. In our current studies, we have explored the potential inhibitory effect and molecular mechanisms underlying isorhapontigenin anticancer effects on anchorage-independent growth of human bladder cancer cell lines. We found that isorhapontigenin showed a significant inhibitory effect on human bladder cancer cell growth and was accompanied with related cell cycle G0–G1 arrest as well as downregulation of cyclin D1 expression at the transcriptional level in UMUC3 and RT112 cells. Further studies identified that isorhapontigenin down- regulated cyclin D1 gene transcription via inhibition of specific protein 1 (SP1) transactivation. Moreover, ectopic expression of GFP-cyclin D1 rendered UMUC3 cells resistant to induction of cell-cycle G0–G1 arrest and inhibition of cancer cell anchorage-independent growth by isorhapontigenin treatment. Together, our studies show that isorhapontigenin is an active compound that mediates Gnetum Cleistostachyum’s induc- tion of cell-cycle G0–G1 arrest and inhibition of cancer cell anchorage-independent growth through down- regulating SP1/cyclin D1 axis in bladder cancer cells. Our studies provide a novel insight into understanding the anticancer activity of the Chinese herb Gnetum Cleistostachyum and its isolate isorhapontigenin. Mol Cancer Ther; 12(8); 1492–503. Ó2013 AACR. Introduction opment (4, 5). A significant proportion of bladder cancer cyclin D1 Bladder cancer is one of the most common cancers cases showed that overexpression of the gene in the Western world and the fifth most common cancer and increased cyclin D1 expression were associated with in the United States (1). According to the American poor prognosis and decreased postoperative patient Cancer Society, 73,510 new cases of bladder cancer are survival (4, 6). Aberrant cyclin D1 expression has been expected to be diagnosed and 14,880 patients will die observed early in carcinogenesis as well (7). Cyclin D1 is from this disease in the United States in 2012. Because a key cell-cycle regulatory protein, playing a critical role high-grade invasive bladder cancers can progress to life in the G1-to-S transition of the cell-cycle progression threatening metastases and are responsible for almost through binding to cyclin-dependent kinase 4 (CDK4) 100% of death from this disease (2, 3), identifying a to phosphorylate (8) and inactivate the retinoblastoma natural compound that specifically inhibits bladder can- protein (pRb; ref. 9), heterozygous deletion of which cer invasion and metastasis is of tremendous importance occurs in approximately 50% of human muscle-invasive for potentially reducing mortality as a result of this bladder cancer. Thus, identifying a new anticancer drug disease. Previous studies have addressed the clinical targeting and downregulating cyclin D1 expression and relevance of cyclin D1 alteration in bladder cancer devel- function is one of the first priorities in the field of anticancer research. Because the multifaced biologic activities of natural oligostibenes, in the past 2 decades, more and more Authors' Affiliations: 1Department of Medical Oncology, Sir Run Run Shaw Hospital, ZheJiang University, Hangzhou, Zhejiang; 2Institute of attention has been focused on the anticancer activities Materia Medica, Chinese Academy of Medical Sciences & Peking Union of this kind of compound (10, 11). Isorhapontigenin Medical College, Beijing, China; 3Nelson Institute of Environmental Med- icine; and 4Departments of Urology and Pathology, New York University, (ISO)isanewderivativeofstilbenecompoundthatwas School of Medicine, New York, New York isolated from the Chinese herb Gnetum Cleistostachyum, Y. Fang, Z. Cao, and Q. Hou contributed equally to this work. which has been used for treatment of bladder cancers for centuries (12). To determine the anticancer activity Corresponding Author: Chuanshu Huang, Nelson Institute of Environ- mental Medicine, New York University School of Medicine, 57 Old Forge and mechanisms of this Chinese herb, in this study, the Road, Tuxedo, NY 10987. Phone: 845-731-3519; Fax: 845-351-2320; potential anticancer activity, inhibition of cyclin D1 E-mail: [email protected] expression as well as molecular events implicated in doi: 10.1158/1535-7163.MCT-12-0922 these activities were elucidated in human bladder can- Ó2013 American Association for Cancer Research. cer cells. 1492 Mol Cancer Ther; 12(8) August 2013 Downloaded from mct.aacrjournals.org on September 29, 2021. © 2013 American Association for Cancer Research. Published OnlineFirst May 30, 2013; DOI: 10.1158/1535-7163.MCT-12-0922 Downregulating Cyclin D1 by ISO in Human Bladder Cancer Materials and Methods DMEM with 2 mmol/L L-glutamine and 25 mg gentamycin Plasmids, antibodies, and reagents and cultured for 24 hours. The cells were then exposed to m The GFP-tagged cyclin D1 expression construct was isorhapontigenin (5 mol/L) for the indicated time. The described in our previous publication (13). The cyclin isorhapontigenin-treated and control cells were harvested D1 promoter-driven luciferase reporter (cyclin D1 Luc) and fixed in 75% ethanol overnight. The cells were then came from Dr. Anil Rustgi (Gastroenterology Division, suspended in staining buffer [containing 0.1% Triton X- 100, 0.2 mg/mL RNase A, and 50 mg/mL propidium University of Pennsylvania, PA; ref. 14). Human cyclin D1 À163 and À163 mSP1 (point mutation at À130 of SP1 iodide (PI)] at 4 C for 1 hour and then DNA content was binding site) promoter-driven luciferase reporter was a gift determined by flow cytometry using a Epics XL flow from Dr. Richard G. Pestell (Kimmel Cancer Center, Thom- cytometer (Beckman Coulter Inc.) and EXPO32 software as Jefferson University, PA; ref. 15). The transcription as previously described in ref. 13. factor Specific protein 1 (SP1) luciferase reporter, contain- ing 3 consensus SPl binding sites, was kindly provided by Anchorage-independent growth assay Dr. Farnham Peggy J (McArdle Laboratory for Cancer The potential isorhapontigenin inhibitory effect of Research, University of Wisconsin, Madison, WI; ref. 16). anchorage-independent growth (soft agar assay) on The antibodies against p53, P-ATFII, were purchased from human bladder cancer cells was determined in UMUC3 Â 4 Cell Signaling Technology. The antibodies against CDK4, cell line (21). In brief, 1 10 UMUC3 cells were exposed to CDK6, FOS (C-FOS), cyclin A, cyclin B1, cyclin D1, cyclin E, various concentrations of isorhapontigenin in 10% FBS p21, and SP1 were obtained from Santa Cruz Biotechnol- Basal Medium Eagle (BME) containing 0.33% soft agar ogy. The antibodies against c-Jun, glyceraldehyde 3-phos- and were seeded over bottom layer of 0.5% agar in 10% FBS/BME in each well of 6-well plates. The cultures were phate dehydrogenase (GAPDH), nuclear factor kappa B (NF-kB) p65, p-c-Jun Ser 63, p-c-Jun Ser 73, and p-NF-kB maintained at 37 Cin5%CO2 incubator for 21 days and p65 were obtained from Cell Signaling Technology. The the cell colonies with more than 32 cells were scored, as antibody against heat shock factor-1 (HSF-1) was obtained described in our previous studies (21, 22). Colonies were from Stressgen Biotechnologies Inc.. The antibody against observed and counted under microscope. The results Æ p27 was obtained from Abcam Inc.. Isorhapontigenin with were presented as mean SD of colony number per purity more than 99% was obtained from Dr. Qi Hou 10,000 seeded cells in soft agar from 3 independent exper- (Institute of Materia Medica, Chinese Academy of Medical iment wells. Sciences & Peking Union Medical College, Beijing, China). Isorhapontigenin was dissolved in dimethyl sulfoxide Animal experiment and isorhapontigenin in vivo (DMSO) to make a stock concentration at 10 mmol/L and pharmacokinetics analysis the same concentration (0.1%, v/v) of DMSO was used as a Thirty Wistar male mice, weighing 20 to 25 g, were negative control in all experiments. purchased from Experimental Animal Center of the Chi- nese Academy of Military Medical Sciences and kept Cell culture and transfection under controlled conditions with a 12-hour light cycle Human bladder cancer cell line RT4, RT112, and UMUC3 with accessing water ad libitum overnight. Mice were then were provided by Dr. Xue-Ru Wu (Departments of Urol- administered with isorhapontigenin (150 mg/kg) via gas- ogy and Pathology, New York University School of Med- tric gavage. Three mice were sacrificed and blood samples icine, New York, NY; ref. 17). Normal mouse epidermal cell were taken at each time points of 0.033, 0.083, 0.17, 0.25, line Cl41 cells were provided by Dr. Zigang Dong (Hormel 0.5, 0.75, 1, 1.5, 2, and 4 hours after isorhapontigenin was Institute, University of Minnesota, Austin, MN; ref. 18–20) given. The serum was collected from each mouse by and was cultured with Eagle’s Minimum Essential Medi- centrifuging of blood sample at 4,000 rpm for 30 minutes À um with 5% FBS, 2 mmol/L L-glutamine, and 25 mg/mL and stored at 20 C for further analyses. To determine gentamycin. All cell lines were subjected to DNA tests and pharmacokinetics of isorhapontigenin in serum of mice, a authenticated before utilization for researches. UMUC3 50 mL aliquot of each serum sample was transferred to 1.5 m cells were maintained at 37 Cina5%CO2 incubator in mL polypropylene tubes, and 300 L methanol (LC grade) Dulbecco’s Modified Eagle Medium (DMEM) supplemen- was added to each sample with vortex for 5 minutes. After ted with 10% FBS, and RT112 cells were cultured with centrifugation for 10 minutes at 10,000 rpm, the superna- RPMI-1640 supplemented with 10% FBS.
Load more

Recommended publications
  • Optimization of Bioactive Polyphenols Extraction from Picea Mariana Bark
    molecules Article Optimization of Bioactive Polyphenols Extraction from Picea Mariana Bark Nellie Francezon 1,2, Naamwin-So-Bâwfu Romaric Meda 1,2 and Tatjana Stevanovic 1,2,* 1 Renewable Materials Research Centre, Department of Wood and Forest Sciences, Université Laval, Québec, QC G1V 0A6, Canada; [email protected] (N.F.); [email protected] (N.-S.-B.R.M.) 2 Institute of Nutrition and Functional Food (INAF), Université Laval, Quebec, QC G1V 0A6, Canada * Correspondence: [email protected]; Tel.: +1-418-656-2131 Received: 30 October 2017; Accepted: 30 November 2017; Published: 1 December 2017 Abstract: Reported for its antioxidant, anti-inflammatory and non-toxicity properties, the hot water extract of Picea mariana bark was demonstrated to contain highly valuable bioactive polyphenols. In order to improve the recovery of these molecules, an optimization of the extraction was performed using water. Several extraction parameters were tested and extracts obtained analyzed both in terms of relative amounts of different phytochemical families and of individual molecules concentrations. As a result, low temperature (80 ◦C) and low ratio of bark/water (50 mg/mL) were determined to be the best parameters for an efficient polyphenol extraction and that especially for low molecular mass polyphenols. These were identified as stilbene monomers and derivatives, mainly stilbene glucoside isorhapontin (up to 12.0% of the dry extract), astringin (up to 4.6%), resveratrol (up to 0.3%), isorhapontigenin (up to 3.7%) and resveratrol glucoside piceid (up to 3.1%) which is here reported for the first time for Picea mariana. New stilbene derivatives, piceasides O and P were also characterized herein as new isorhapontin dimers.
    [Show full text]
  • Literature Review Zero Alcohol Red Wine
    A 1876 LI A A U R S T T S R U A L A I A FLAVOURS, FRAGRANCES AND INGREDIENTS 6 1 7 8 7 8 1 6 A I B A L U A S R T B Essential Oils, Botanical Extracts, Cold Pressed Oils, BOTANICAL Infused Oils, Powders, Flours, Fermentations INNOVATIONS LITERATURE REVIEW HEALTH BENEFITS RED WINE ZERO ALCOHOL RED WINE RED WINE EXTRACT POWDER www.botanicalinnovations.com.au EXECUTIVE SUMMARY The term FRENCH PARADOX is used to describe the relatively low incidence of cardiovascular disease in the French population despite the high consumption of red wine. Over the past 27 years numerous clinical studies have found a linkages with the ANTIOXIDANTS in particular, the POLYPHENOLS, RESVERATROL, CATECHINS, QUERCERTIN and ANTHOCYANDINS in red wine and reduced incidences of cardiovascular disease. However, the alcohol in wine limits the benefits of wine. Studies have shown that zero alcohol red wine and red wine extract which contain the same ANTIOXIDANTS including POLYPHENOLS, RESVERATROL, CATECHINS, QUERCERTIN and ANTHOCYANDINS has the same is not more positive health benefits. The following literature review details some of the most recent positive health benefits derived from the ANTIOXIDANTS found in red wine POLYPHENOLS: RESVERATROL, CATECHINS, QUERCERTIN and ANTHOCYANDINS. The positive polyphenolic antioxidant effects of the polyphenols in red wine include: • Cardio Vascular Health Benefits • Increase antioxidants in the cardiovascular system • Assisting blood glucose control • Skin health • Bone Health • Memory • Liking blood and brain health • Benefits
    [Show full text]
  • Molecular Cloning and Functional Characterization of an O-Methyltransferase Catalyzing 4 -O-Methylation of Resveratrol in Acorus
    Journal of Bioscience and Bioengineering VOL. 127 No. 5, 539e543, 2019 www.elsevier.com/locate/jbiosc Molecular cloning and functional characterization of an O-methyltransferase catalyzing 40-O-methylation of resveratrol in Acorus calamus Takao Koeduka,1,* Miki Hatada,1 Hideyuki Suzuki,2 Shiro Suzuki,3 and Kenji Matsui1 Graduate School of Sciences and Technology for Innovation (Agriculture), Department of Biological Chemistry, Yamaguchi University, Yamaguchi 753-8515, Japan,1 Department of Applied Genomics, Kazusa DNA Research Institute, Chiba 292-0818, Japan,2 and Research Institute for Sustainable Humanosphere, Kyoto University, Kyoto 611-0011, Japan3 Received 17 July 2018; accepted 13 October 2018 Available online 22 November 2018 Resveratrol and its methyl ethers, which belong to a class of natural polyphenol stilbenes, play important roles as biologically active compounds in plant defense as well as in human health. Although the biosynthetic pathway of resveratrol has been fully elucidated, the characterization of resveratrol-specific O-methyltransferases remains elusive. In this study, we used RNA-seq analysis to identify a putative aromatic O-methyltransferase gene, AcOMT1,inAcorus calamus. Recombinant AcOMT1 expressed in Escherichia coli showed high 40-O-methylation activity toward resveratrol and its derivative, isorhapontigenin. We purified a reaction product enzymatically formed from resveratrol by AcOMT1 and confirmed it as 40-O-methylresveratrol (deoxyrhapontigenin). Resveratrol and isorhapontigenin were the most preferred substrates with apparent Km values of 1.8 mM and 4.2 mM, respectively. Recombinant AcOMT1 exhibited reduced activity toward other resveratrol derivatives, piceatannol, oxyresveratrol, and pinostilbene. In contrast, re- combinant AcOMT1 exhibited no activity toward pterostilbene or pinosylvin. These results indicate that AcOMT1 showed high 40-O-methylation activity toward stilbenes with non-methylated phloroglucinol rings.
    [Show full text]
  • Resveratrol 98% Natural (Japanese Knotweed)
    Resveratrol 98% Natural (Japanese Knotweed) Cambridge Commodities Chemwatch Hazard Alert Code: 3 Part Number: P33926 Issue Date: 04/03/2019 Version No: 1.1.23.11 Print Date: 29/09/2021 Safety data sheet according to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 S.REACH.GB.EN SECTION 1 Identification of the substance / mixture and of the company / undertaking 1.1. Product Identifier Product name Resveratrol 98% Natural (Japanese Knotweed) Chemical Name resveratrol Synonyms Not Available Chemical formula Not Applicable Other means of P33926 identification 1.2. Relevant identified uses of the substance or mixture and uses advised against The pharmacological activities and mechanisms of action of natural phenylpropanoid glycosides (PPGs) extracted from a variety of plants such as antitumor, antivirus, anti-inflammation, antibacteria, antiartherosclerosis, anti-platelet-aggregation, antihypertension, antifatigue, analgesia, hepatoprotection, immunosuppression, protection of sex and learning behavior, protection of neurodegeneration, reverse transformation of tumor cells, inhibition of telomerase and shortening telomere length in tumor cells, effects on enzymes and cytokines, antioxidation, free radical scavenging and fast repair of oxidative damaged DNA, have been reported in the literature. Phenylpropanoids (PPs) belong to the largest group of secondary metabolites produced by plants, mainly, in response to biotic or abiotic stresses such as infections, wounding, UV irradiation, exposure to ozone, pollutants, and other hostile environmental conditions. It is thought that the molecular basis for the protective action of phenylpropanoids in plants is their antioxidant and free radical scavenging properties. These numerous phenolic compounds are major biologically active components of human diet, spices, aromas, wines, beer, essential oils,propolis, and traditional medicine.
    [Show full text]
  • Biotechnological Advances in Resveratrol Production and Its Chemical Diversity
    Review Biotechnological Advances in Resveratrol Production and its Chemical Diversity Samir Bahadur Thapa 1,†, Ramesh Prasad Pandey 1,2,†, Yong Il Park 3 and Jae Kyung Sohng 1,2,* 1 Department of Life Science and Biochemical Engineering, Sun Moon University, Chungnam 31460, Korea 2 Department of Pharmaceutical Engineering and Biotechnology, Sun Moon University, Chungnam 31460, Korea 3 Department of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi-do 14662, Korea * Correspondence: [email protected] † Contributed equally to prepare this review article. Received: 3 June 2019; Accepted: 1 July 2019; Published: 15 July 2019 Abstract The very well-known bioactive natural product, resveratrol (3,5,4′-trihydroxystilbene), is a highly studied secondary metabolite produced by several plants, particularly grapes, passion fruit, white tea, and berries. It is in high demand not only because of its wide range of biological activities against various kinds of cardiovascular and nerve-related diseases, but also as important ingredients in pharmaceuticals and nutritional supplements. Due to its very low content in plants, multi-step isolation and purification processes, and environmental and chemical hazards issues, resveratrol extraction from plants is difficult, time consuming, impracticable, and unsustainable. Therefore, microbial hosts, such as Escherichia coli, Saccharomyces cerevisiae, and Corynebacterium glutamicum, are commonly used as an alternative production source by improvising resveratrol biosynthetic genes in them. The biosynthesis genes are rewired applying combinatorial biosynthetic systems, including metabolic engineering and synthetic biology, while optimizing the various production processes. The native biosynthesis of resveratrol is not present in microbes, which are easy to manipulate genetically, so the use of microbial hosts is increasing these days.
    [Show full text]
  • Isorhapontigenin, a Resveratrol Analogue Selectively Inhibits ADP-Stimulated Platelet Activation
    Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation Article Accepted Version Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0 Ravishankar, D., Albadawi, D., Chaggar, V., Patra, P., Williams, H., Salamah, M., Vaiyapuri, R., Dash, P., Patel, K., Watson, K. and Vaiyapuri, S. (2019) Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation. European Journal of Pharmacology, 862. 172627. ISSN 0014-2999 doi: https://doi.org/10.1016/j.ejphar.2019.172627 Available at http://centaur.reading.ac.uk/85806/ It is advisable to refer to the publisher’s version if you intend to cite from the work. See Guidance on citing . To link to this article DOI: http://dx.doi.org/10.1016/j.ejphar.2019.172627 Publisher: Elsevier All outputs in CentAUR are protected by Intellectual Property Rights law, including copyright law. Copyright and IPR is retained by the creators or other copyright holders. Terms and conditions for use of this material are defined in the End User Agreement . www.reading.ac.uk/centaur CentAUR Central Archive at the University of Reading Reading’s research outputs online Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation 1 1 1 1 Divyashree Ravishankar , Dina A I Albadawi , Vishaant Chaggar , Pabitra H Patra , Harry F Williams1, Maryam Salamah1, Rajendran Vaiyapuri2, Philip R Dash3, Ketan Patel3, Kimberly A Watson3, Sakthivel Vaiyapuri1♯ 1School of Pharmacy, University of Reading, Reading, UK 2School of Pharmacy, University of Reading Malaysia, Johor, Malaysia 3School of Biological Sciences, University of Reading, Reading, UK Corresponding Author ♯Sakthivel Vaiyapuri, School of Pharmacy, University of Reading, Reading, UK Tel: +44 (0)118 378 8015 E-mail address: [email protected] 1 Abstract Isorhapontigenin is a polyphenolic compound found in Chinese herbs and grapes.
    [Show full text]
  • Review Article Polyphenol Stilbenes: Molecular Mechanisms of Defence Against Oxidative Stress and Aging-Related Diseases
    Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2015, Article ID 340520, 24 pages http://dx.doi.org/10.1155/2015/340520 Review Article Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases Mika Reinisalo,1 Anna Kårlund,2 Ali Koskela,1,2 Kai Kaarniranta,1,3 and Reijo O. Karjalainen2 1 DepartmentofOphthalmology,UniversityofEasternFinland,P.O.Box1627,70211Kuopio,Finland 2DepartmentofBiology,UniversityofEasternFinland,P.O.Box1627,70211Kuopio,Finland 3Department of Ophthalmology, Kuopio University Hospital, P.O. Box 1627, 70211 Kuopio, Finland Correspondence should be addressed to Mika Reinisalo; [email protected] Received 11 October 2014; Accepted 21 January 2015 Academic Editor: David Vauzour Copyright © 2015 Mika Reinisalo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Numerous studies have highlighted the key roles of oxidative stress and inflammation in aging-related diseases such as obesity, type 2 diabetes, age-related macular degeneration (AMD), and Alzheimer’s disease (AD). In aging cells, the natural antioxidant capacity decreases and the overall efficiency of reparative systems against cell damage becomes impaired. There is convincing data that stilbene compounds, a diverse group of natural defence phenolics, abundant in grapes, berries, and conifer bark waste, may confer a protective effect against aging-related diseases. This review highlights recent data helping to clarify the molecular mechanisms involved in the stilbene-mediated protection against oxidative stress. The impact of stilbenes on the nuclear factor-erythroid-2- related factor-2 (Nrf2) mediated cellular defence against oxidative stress as well as the potential roles of SQSTM1/p62 protein in Nrf2/Keap1 signaling and autophagy will be summarized.
    [Show full text]
  • Stability and Photoisomerization of Stilbenes Isolated from the Bark of Norway Spruce Roots
    molecules Article Stability and Photoisomerization of Stilbenes Isolated from the Bark of Norway Spruce Roots Harri Latva-Mäenpää 1,2,* , Riziwanguli Wufu 1 , Daniel Mulat 1, Tytti Sarjala 3, Pekka Saranpää 3,* and Kristiina Wähälä 1,4,* 1 Department of Chemistry, University of Helsinki, P.O. Box 55, FI-00014 Helsinki, Finland; riziwanguli.wufu@helsinki.fi (R.W.); [email protected] (D.M.) 2 Foodwest, Kärryväylä 4, FI-60100 Seinäjoki, Finland 3 Natural Resources Institute Finland, Tietotie 2, FI-02150 Espoo, Finland; tytti.sarjala@luke.fi 4 Department of Biochemistry and Developmental Biology, University of Helsinki, P.O. Box 63, FI-00014 Helsinki, Finland * Correspondence: harri.latva-maenpaa@foodwest.fi (H.L.-M.); pekka.saranpaa@luke.fi (P.S.); kristiina.wahala@helsinki.fi (K.W.); Tel.: +358-50-4487502 (H.L.-M. & P.S. & K.W.) Abstract: Stilbenes or stilbenoids, major polyphenolic compounds of the bark of Norway spruce (Picea abies L. Karst), have potential future applications as drugs, preservatives and other functional ingredients due to their antioxidative, antibacterial and antifungal properties. Stilbenes are photosen- sitive and UV and fluorescent light induce trans to cis isomerisation via intramolecular cyclization. So far, the characterizations of possible new compounds derived from trans-stilbenes under UV light exposure have been mainly tentative based only on UV or MS spectra without utilizing more detailed structural spectroscopy techniques such as NMR. The objective of this work was to study the stability Citation: Latva-Mäenpää, H.; Wufu, of biologically interesting and readily available stilbenes such as astringin and isorhapontin and R.; Mulat, D.; Sarjala, T.; Saranpää, P.; their aglucones piceatannol and isorhapontigenin, which have not been studied previously.
    [Show full text]
  • Stilbenoids: a Natural Arsenal Against Bacterial Pathogens
    antibiotics Review Stilbenoids: A Natural Arsenal against Bacterial Pathogens Luce Micaela Mattio , Giorgia Catinella, Sabrina Dallavalle * and Andrea Pinto Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133 Milan, Italy; [email protected] (L.M.M.); [email protected] (G.C.); [email protected] (A.P.) * Correspondence: [email protected] Received: 18 May 2020; Accepted: 16 June 2020; Published: 18 June 2020 Abstract: The escalating emergence of resistant bacterial strains is one of the most important threats to human health. With the increasing incidence of multi-drugs infections, there is an urgent need to restock our antibiotic arsenal. Natural products are an invaluable source of inspiration in drug design and development. One of the most widely distributed groups of natural products in the plant kingdom is represented by stilbenoids. Stilbenoids are synthesised by plants as means of protection against pathogens, whereby the potential antimicrobial activity of this class of natural compounds has attracted great interest in the last years. The purpose of this review is to provide an overview of recent achievements in the study of stilbenoids as antimicrobial agents, with particular emphasis on the sources, chemical structures, and the mechanism of action of the most promising natural compounds. Attention has been paid to the main structure modifications on the stilbenoid core that have expanded the antimicrobial activity with respect to the parent natural compounds, opening the possibility of their further development. The collected results highlight the therapeutic versatility of natural and synthetic resveratrol derivatives and provide a prospective insight into their potential development as antimicrobial agents.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0067296A1 Brownell Et Al
    US 20160067296A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0067296A1 BrOWnell et al. (43) Pub. Date: Mar. 10, 2016 (54) COMPOSITIONS AND METHODS FOR JOINT Publication Classification HEALTH (51) Int. Cl. (71) Applicants: Unigen, Inc., Seattle, WA (US); Unigen, A61E36/605 (2006.01) Inc., Cheonan-si (KR) A613 L/7034 (2006.01) A613 L/352 (2006.01) (72) Inventors: Lidia Alfaro Brownell, Tacoma, WA A63L/05 (2006.01) (US); Min Chu, Newcastle, WA (US); A61E36/48 (2006.01) Mei-Feng Hong, Lacey, WA (US); A613 L/353 (2006.01) Eu-Jin Hyun, Cheonan-si (KR); Qi Jia, (52) U.S. Cl. Olympia, WA (US); Ping Jiao, CPC ............... A61K 36/605 (2013.01); A61K 36/48 Newcastle, WA (US); Young-Chul Lee, (2013.01); A61 K3I/353 (2013.01); A61 K Daejeon (KR); Mesfin Yimam, Tacoma, 3 1/352 (2013.01); A61 K3I/05 (2013.01); WA (US) A61 K3I/7034 (2013.01) (73) Assignee: UNIGEN, INC., Seattle, WA (US) (57) ABSTRACT (21) Appl. No.: 14/853,063 The present disclosure provides mixtures of prenylated fla vonoids, stilbenes, or both with flavans or curcuminoids or (22) Filed: Sep. 14, 2015 both capable of modulating joint inflammation, joint pain, joint stiffness, cartilage degradation, or improving mobility, Related U.S. Application Data range of motion, flexibility, joint physical function, or any combination thereof. Such a mixture of prenylated fla (63) Continuation of application No. 14/305,839, filed on vonoids, stilbenes, or both with flavans or curcuminoids or Jun. 16, 2014. both can optionally be used in combination with other joint (60) Provisional application No.
    [Show full text]
  • Biological/Chemopreventive Activity of Stilbenes and Their Effect on Colon Cancer
    Review 1635 Biological/Chemopreventive Activity of Stilbenes and their Effect on Colon Cancer Author Agnes M. Rimando1, Nanjoo Suh2, 3 Affiliation 1 United States Department of Agriculture, Agricultural Research Service, Natural Products Utilization Research Unit, University, MS, USA 2 Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA 3 The Cancer Institute of New Jersey, New Brunswick, NJ, USA Key words Abstract ventive agents. One of the best-characterized ●" resveratrol ! stilbenes, resveratrol, has been known as an anti- ●" stilbenes Colon cancer is one of the leading causes of can- oxidant and an anti-aging compound as well as ●" colon cancer cer death in men and women in Western coun- an anti-inflammatory agent. Stilbenes have di- ●" inflammation tries. Epidemiological studies have linked the verse pharmacological activities, which include consumption of fruits and vegetables to a re- cancer prevention, a cholesterol-lowering effect, duced risk of colon cancer, and small fruits are enhanced insulin sensitivity, and increased life- particularly rich sources of many active phyto- span. This review summarizes results related to chemical stilbenes, such as resveratrol and pter- the potential use of various stilbenes as cancer ostilbene. Recent advances in the prevention of chemopreventive agents, their mechanisms of colon cancer have stimulated an interest in diet action, as well as their pharmacokinetics and ef- and lifestyle as an effective means of interven- ficacy for the prevention of colon cancer in ani- tion. As constituents of small fruits such as mals and humans. grapes, berries and their products, stilbenes are under intense investigation as cancer chemopre- received May 7, 2008 Introduction wood in response to fungal infection [5], [6].
    [Show full text]
  • Bioactive Phenolic Compounds, Metabolism and Properties: a Review on Valuable Chemical Compounds in Scots Pine and Norway Spruce
    Phytochem Rev https://doi.org/10.1007/s11101-019-09630-2 (0123456789().,-volV)( 0123456789().,-volV) Bioactive phenolic compounds, metabolism and properties: a review on valuable chemical compounds in Scots pine and Norway spruce Sari Metsa¨muuronen . Heli Sire´n Received: 30 January 2019 / Accepted: 5 July 2019 Ó The Author(s) 2019 Abstract Phenolics and extracted phenolic com- effects between aglycones and their glycosides have pounds of Scots pine (Pinus sylvestris) and Norway been observed. Minimum inhibition concentrations of spruce (Picea abies) show antibacterial activity below 10 mg L-1 against bacteria have been reported against several bacteria. The majority of phenolic for gallic acid, apigenin, and several methylated and compounds are stilbenes, flavonoids, proanthocyani- acylated flavonols present in these industrially impor- dins, phenolic acids, and lignans that are biosynthe- tant trees. In general, the phenolic compounds are sized in the wood through the phenylpropanoid more active against Gram-positive bacteria, but api- pathway. In Scots pine (P. sylvestris), the most genin is reported to exhibit strong activity against abundant phenolic and antibacterial compounds are Gram-negative bacteria. The present review lists some pinosylvin-type stilbenes and flavonol- and dihy- of the biosynthesis pathways for the antibacterial droflavonol-type flavonoids, such as kaempferol, phenolic metabolites found in Scots pine (P. sylves- quercetin, and taxifolin and their derivatives. In tris) and Norway spruce (P. abies). The antimicrobial Norway spruce (P. abies) on the other hand, the main activity of the compounds is collected and compared stilbene is resveratrol and the major flavonoids are to gather information about the most effective sec- quercetin and myricetin.
    [Show full text]